The PRESTO (prevention of restenosis with tranilast and its outcomes) protocol: A double-blind, placebo-controlled trial

American Heart Journal

Volumn 139, Issue 1 I, 2000, Pages 23-31

  Holmes, David ^a   Fitzgerald, Peter ^b   Goldberg, Sheldon ^c   LaBlanche, J M ^d   Lincoff, A Michael ^e   Savage, Michael ^f   Serruys, P W ^g   Willerson, James ^h   Granett, Jeffrey R ⁱ   Chan, Robert ⁱ   Shusterman, Neil H ⁱ   Poland, Marcia ⁱ  

^a MAYO CLINIC   (United States)

^b STANFORD UNIVERSITY   (United States)

^c Department of Anesthesiology   (United States)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e LERNER RESEARCH INSTITUTE   (United States)

^f THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^g Heartcentre   (Netherlands)

^h UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

ⁱ SmithKline Beecham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; COLLAGEN; CYCLOOXYGENASE 2; CYTOKINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; PLATELET DERIVED GROWTH FACTOR; TRANILAST; TRANSFORMING GROWTH FACTOR BETA1; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CLINICAL TRIAL; COLLAGEN SYNTHESIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; DRUG SAFETY; FEMALE; FOLLOW UP; HEALTH ECONOMICS; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESTENOSIS; SMOOTH MUSCLE FIBER; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR SMOOTH MUSCLE;

EID: 0033973506     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(00)90304-1     Document Type: Article

References (22)

1. Serruys PW, deJaegere M, Kiemaeneig F, et al for the Benestent Study Group. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. New Engl J Med 1994;331:489-95.
2. Fischman DL, Leon MB, Baim DS, et al for STRESS (Stent Restenosis Study Investigators). A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501.
3. Nobuyoshi M, Kimura T, Nosaka H, et al. Restenosis after successful coronary angioplasty: serial angiographic follow-up of 229 patients. J Am Coll Cardiol 1988;12:616-23.
4. Savage MP, Fischman DL, Rake R, et al. Efficacy of coronary stenting vs balloon angioplasty in small coronary arteries. J Am Coll Cardiol 1998;31:307-11.
5. Inoue H, Oshima H, Kono H, et al. Suppressive effects of tranilast on the expression of inducible cyclooxygenase (COX2) in interleukin-1β-stimulated fibroblasts. Biochem Pharmacol 1997;53:1941-4.
6. Hishikawa K, Nakaki T, Hirahashi J, Marumo T, Saruta T. Tranilast restores cytokine-induced nitric oxide production against plateletderived growth factor in vascular smooth muscle cells. J Cardiovascular Pharmacol 1996;28:200-7.
7. Fukuyama J, Ichikawa K, Miyazawa K, et al. Tranilast supprersses intimal hyperplasia in the balloon injury model and cuff treatment model in rabbits. Jpn J Pharmacol 1996;70:321-7.
8. Fukuyama J, Ichikawa K, Hamano S, Shibato N. Tranilast suppresses the vascular intimal hyperplasia after balloon injury in rabbits fed a high cholesterol diet. Eur J Pharmacol 1996;318:327-32.
9. Ichikawa K, Fukuyama J, Miyazawa K, et al. Suppressive effect of an anti-allergic drug, tranilast, on the vascular intimal thicking by balloon catheter. Pharmacometrics 1995;50:539-45.
10. Kikuchi S, Umemura K, Kondo K, Nasashima M. Tranilast suppresses intimal hyperplasia after photochemically induced endothelial injury in the rat. Eur J Pharmacol 1996;295:221-7.
11. Ishiwata S, Chronos NAF, Lin G, et al. Tranilast inhibits neointimal formation in balloon-injured and stented pig coronary arteries and decreases negative remodelling after injury [abstract]. J Am Coll Cardiol 1998;31:144A.
12. Tamai H, for the Treat Group. Inhibitory effect of tranilast on restenosis after percutaneous transluminal coronary angioplasty (PTCA). Results of a late phase II clinical placebo controlled double blind study. J Clin Exp Medicine 1995;175:577-94.
13. Tamai H, et al. Clinical evaluation of tranilast in the prevention of restenosis after percutaneous transluminal coronary angioplasty (PTCA). A phase III multicenter randomized double blind placebo-controlled trial. J Clin Therap Med 1996;12:65-85.
14. Hsu Y-S, Tamai H, et al. Efficacy of of tranilast on restenosis after coronary stenting [abstract]. Circulation 1996;94 (suppl):I-620.
15. Kosuga K, Tamai H Uedo K, et al. Effectiveness of tranilast on restenosis after directional coronary atherectomy. Am Heart J 1997;134:712-8.
16. Package insert of Rizaben (tranilast). Toyko: Kissei Pharmaceutical; 1998.
17. The EPISTENT Investigators. Randomised placebo-controlled and balloon-angioplasty - controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb/IIIa blockade. Lancet 1998;352:87-92.
18. Hausleiter J, et al. Comparison of different quantitative coronary analysis systems: ARTREK, CAAS, and CMS. Cathet Cardiovasc Diagn 1996;37:14-22.
19. Reiber JHC, Serruys PW, editors. Progress in quantitative coronary arteriography. Dordrecht: Kluwer Academic; 1994.
20. Hockberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988;75:800-2.
21. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying comorbidity in longitudinal studies: development and validation. J Chron Dis 1987;40:373-83.
22. Tardif J-C, Cote G, Lesperance J. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. New Engl J Med 1997;337:365-72.